A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma.
about
Biomarkers for use in monitoring responses of nasopharyngeal carcinoma cells to ionizing radiationEpstein-Barr virus WZhet DNA can induce lytic replication in epithelial cells in vitro, although WZhet is not detectable in many human tissues in vivo.Epstein-Barr virus Zta upregulates matrix metalloproteinases 3 and 9 that synergistically promote cell invasion in vitro.Generation and characterization of a novel recombinant antibody against LMP1-TES1 of Epstein-Barr virus isolated by phage display.Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicityCurrent and emerging treatment options for nasopharyngeal carcinoma.Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma.Evaluation of a multianalyte profiling assay and an enzyme-linked immunosorbent assay for serological examination of Epstein-Barr virus-specific antibody responses in diagnosis of nasopharyngeal carcinoma.Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.Serum Zta antibody of Epstein-Barr virus exerts potential function in the diagnosis of nasopharyngeal cancer.The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications.Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum.Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis.High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease.Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum
P2860
Q27010624-52791A5B-640C-4E1D-8BB1-7407841597ACQ33832940-ED7BC859-11A8-448D-9D2D-BA08320F1B6AQ34586675-8327E308-438D-40FD-AE76-BD1DCAB60EB1Q34682093-C0772533-833F-4AE5-9650-8729D6D75C09Q35783467-B142B013-F7E1-4D38-A891-B4183C53F4C2Q36359374-5A3AD441-9E2C-420F-884C-AB5741E1A3ABQ36399124-5D2B00D8-9473-433C-A0DB-75B8517D0A36Q36609904-C6FF458F-7848-432A-B80F-1B1CDC165A0DQ36974327-45843FC4-7C42-4AED-B010-1A9BBD5CB7E3Q37325545-26D6DD03-9634-48F0-AD0A-06622BA0202EQ38398399-2DAE2A0F-C957-4B2E-8472-9540EE463FC2Q39344275-600F4C3E-D4CE-4762-9FCA-2E05A852C56CQ39396128-EC2F3063-EB0B-4010-A4CD-59F4E3A56882Q43824339-F80CCC3F-C4E0-4B97-962D-DF424869891EQ45750564-25C16617-8A6E-42EA-9D75-5EA29621814BQ57262055-B0491BD3-9A55-4DBD-902A-9A7398E83369
P2860
A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
A possible prognostic role of ...... with nasopharyngeal carcinoma.
@en
A possible prognostic role of ...... with nasopharyngeal carcinoma.
@nl
type
label
A possible prognostic role of ...... with nasopharyngeal carcinoma.
@en
A possible prognostic role of ...... with nasopharyngeal carcinoma.
@nl
prefLabel
A possible prognostic role of ...... with nasopharyngeal carcinoma.
@en
A possible prognostic role of ...... with nasopharyngeal carcinoma.
@nl
P2093
P2860
P1433
P1476
A possible prognostic role of ...... with nasopharyngeal carcinoma.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(19941101)74:9<2414::AID-CNCR2820740905>3.0.CO;2-8
P407
P577
1994-11-01T00:00:00Z